Results 201 to 210 of about 6,524,554 (346)
Loss of the miR‐214/199a cluster is associated with recurrence in ovarian cancer. Engineered small extracellular vesicles (m214‐sEVs) elevate miR‐214‐3p/miR‐199a‐5p in tumor cells, suppress β‐catenin, TLR4, and YKT6 signaling, reprogram tumor‐derived sEV cargo, reduce chemoresistance and migration, and enhance carboplatin efficacy and survival in ...
Weida Wang +12 more
wiley +1 more source
Fault-tolerant formation control of heterogeneous multi-agent systems with unknown inputs and external disturbances. [PDF]
Li Y, Liu Y, Zhu L, Guo Y.
europepmc +1 more source
PIN49 SPREAD PATTERN FORMATION OF H5NI-AVIAN INFLUENZA AND ITS IMPLICATIONS FOR CONTROL STRATEGIES
VRSK Duwuri, Runjuan Liu, Jtk Wu
openalex +1 more source
Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann +61 more
wiley +1 more source
In-Orbit Optimal Safe Formation Control for Surrounding an Unknown Huge Target with Specific Structure by Using Relative Sensors Only. [PDF]
Wei B, Li C, Dang Z, Yue X.
europepmc +1 more source
Formation and control of heterocyclic amines and polycyclic aromatic hydrocarbons during meat processing [PDF]
Fei Lü
openalex
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla +9 more
wiley +1 more source
Trajectory tracking and formation control of quadrotor UAVs based on modified super twisting sliding mode method. [PDF]
Dou J, Wu Y, Xie D, Zhang T.
europepmc +1 more source

